U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H16ClN5O2
Molecular Weight 381.816
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AZD-2066

SMILES

C[C@@H](OC1=NN=C(N1C)C2=CC=NC=C2)C3=NOC(=C3)C4=CC(Cl)=CC=C4

InChI

InChIKey=SXWHYTICXCLKDG-GFCCVEGCSA-N
InChI=1S/C19H16ClN5O2/c1-12(16-11-17(27-24-16)14-4-3-5-15(20)10-14)26-19-23-22-18(25(19)2)13-6-8-21-9-7-13/h3-12H,1-2H3/t12-/m1/s1

HIDE SMILES / InChI

Molecular Formula C19H16ClN5O2
Molecular Weight 381.816
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 01:50:29 UTC 2023
Edited
by admin
on Sat Dec 16 01:50:29 UTC 2023
Record UNII
MQ908Y1ZB2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZD-2066
Common Name English
AZD 2066 [WHO-DD]
Common Name English
AZD2066
Common Name English
PYRIDINE, 4-(5-((1R)-1-(5-(3-CHLOROPHENYL)-3-ISOXAZOLYL)ETHOXY)-4-METHYL-4H-1,2,4-TRIAZOL-3-YL)-
Systematic Name English
Code System Code Type Description
ChEMBL
CHEMBL3545164
Created by admin on Sat Dec 16 01:50:29 UTC 2023 , Edited by admin on Sat Dec 16 01:50:29 UTC 2023
PRIMARY
CAS
934282-55-0
Created by admin on Sat Dec 16 01:50:29 UTC 2023 , Edited by admin on Sat Dec 16 01:50:29 UTC 2023
PRIMARY
SMS_ID
100000175777
Created by admin on Sat Dec 16 01:50:29 UTC 2023 , Edited by admin on Sat Dec 16 01:50:29 UTC 2023
PRIMARY
DRUG BANK
DB12644
Created by admin on Sat Dec 16 01:50:29 UTC 2023 , Edited by admin on Sat Dec 16 01:50:29 UTC 2023
PRIMARY
FDA UNII
MQ908Y1ZB2
Created by admin on Sat Dec 16 01:50:29 UTC 2023 , Edited by admin on Sat Dec 16 01:50:29 UTC 2023
PRIMARY
PUBCHEM
16041426
Created by admin on Sat Dec 16 01:50:29 UTC 2023 , Edited by admin on Sat Dec 16 01:50:29 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
ANTAGONIST
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY